Welcome to the e-CCO Library!

P091: A single-cell RNAseq approach to understand and predict the efficacy of tofacitinib in Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Melon, E.(1);Corraliza, A.M.(1);Garrido, A.(1);Veny, M.(1);Masamunt, M.C.(1);Giner, A.(1);Ordás, I.(1);Fernández, A.(1);Ricart, E.(1);Panés, J.(1);Salas, A.(1);
Created: Friday, 11 February 2022, 3:52 PM
P091: Gender focused investigation of sexual dysfunction, sexual satisfaction and body schema disorders in male and female patients with Inflammatory Bowel Disease
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Kranzeder, A.(1);Lindenthal, D.(2);Hirning, C.(1);von Wietersheim, J.(1);Klaus, J.(2)*;
Created: Friday, 14 July 2023, 10:48 AM
P091: Increased paracellular permeability in colonic biopsies from patients with ulcerative colitis in remission compared with patients with irritable bowel syndrome
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

G. Katinios*1, S. A. Walter1, M. Vicario2, A. M. González-Castro2, J. D. Söderholm3, H. Hjortswang1, Å. V. Keita4

Created: Friday, 22 February 2019, 9:41 AM
P091: Inflammation in relation to mucosal barrier function in chronic colitis: a study in time
Year: 2018
Source: ECCO '18 Vienna
Authors:

H. Van Spaendonk1*, J. De Man1, S. Francque1,2, H. De Schepper1,2, B. De Winter1

Created: Thursday, 21 February 2019, 9:14 AM
P091: Sonic hedgehog inhibitor prevented colitis-associated cancer via stem inhibition
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

K. B. Hahm*1, Y. J. Kim2

Created: Friday, 22 February 2019, 9:49 AM
P091: Switching to TNFi versus non-TNFi biologics in Crohn’s Disease patients: Real-world outcomes from a German claims data analysis
Year: 2021
Source: ECCO'21 Virtual
Authors: Antolin-Fontes, B.(1);Borsi, A.(2);Nissinen, R.(3);Bravatà, I.(4);Barthelmes, J.N.(5);Le Bars, M.(6);Lee, J.(2);Maywald, U.(7);Bokemeyer, B.(8);Wilke, T.(9);Ghiani, M.(9);
Created: Wednesday, 2 June 2021, 4:12 PM
P091: Usefulness of transcriptional whole blood biomarkers as a non-invasive surrogate marker of mucosal healing and endoscopic response in ulcerative colitis
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Planell N.*1,2, Masamunt M.C.1, Franco Leal R.3, Rodríguez L.4, Esteller M.1, Lozano J.J.2, Ramírez A.1, Setsuko Ayrizono M.d.L.3, Saddy Rodrigues Coy C.3, Alfaro I.1, Ordás I.1, Visvanathan S.5, Ricart E.1, Guardiola J.4, Panés J.1, Salas A.1

Created: Wednesday, 20 February 2019, 10:36 AM
P092 Pathogenic B-cell response in ulcerative colitis that associates with treatment resistance and disease complications
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Uzzan1, J. Martin2, E. Keningsberg2, T. Castro-Dopico3, R. Huang4, R. Ungaro1, B. Cohen1, A. Rahman5, A. Rosenstein1, S. Gurunathan1, M. Dubinsky1, M. Clatworthy3, M. Suarez-Farinas6, C. Argmann6, J.F. Colombel1, S. Mehandru7

Created: Thursday, 30 January 2020, 10:12 AM
P092: Characterisation of the lymphoid stress surveillance response performed by human colon resident γδ T-cells
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

R. J. Dart*1, 2, 3, R. Woolf2, P. M. Irving3, A. C. Hayday1, 2

Created: Friday, 22 February 2019, 9:49 AM
P092: Circulating classical monocytes and intestinal macrophages exhibit reduced response to IL-10 in IBD
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

I. Hoti*1, N. McCarthy1, E. Giles1, I. Ayada1, P. Harrow1, H. Gordon1, A. Stagg1, J. Lindsay1

Created: Friday, 22 February 2019, 9:41 AM
P092: Development and evaluation of i-Tracker Ustekinumab and i-Tracker Anti-ustekinumab kits: fast and innovative chemiluminescent assays for the monitoring of patients treated with ustekinumab
Year: 2021
Source: ECCO'21 Virtual
Authors: Noguier, G.(1);Montaillier, C.(1);Daviere, S.(2);Yang, Y.(2);Colombeau, L.(1);Parussini, E.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P092: Exogenous administration of IL-4-treated macrophages prevents intestinal fibrosis in Stat6 knockout mice
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Salvador P.*1, Ortiz-Masià D.1, Macias-Ceja D.C.2, Gisbert-Ferrándiz L.1, Hernández C.2,3, Esplugues J.V.1,2,3, Barrachina-Sancho M.D.1,3, Calatayud S.1,3

Created: Wednesday, 20 February 2019, 10:36 AM
P092: Humoral and T cell responses to COVID-19 vaccination in IBD
Year: 2022
Source: ECCO'22
Authors: Zhang, E.(1);Bond, K.(2);Nguyen, O.(3);Allen, L.(3);Kedzierski , L.(3);Kedzierka, K.(3);Christensen, B.(1);
Created: Friday, 11 February 2022, 3:52 PM
P092: Punica Granatum affects gut biofilm-forming bacteria and promotes intestinal mucosal healing regulating the crosstalk between epithelial cells and intestinal fibroblasts
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Rizzo, G.(1,2)*;Pineda Chavez, S.E.(1,2);Vandenkoornhuyse, E.(1);Cardenas, C.(1);Cento, V.(1,3);Meanti, L.(2);Roda, G.(4);Loy, L.(5);Dal Buono, A.(5);Gabbiadini, R.(5);Lovisa, S.(1);Rusconi, R.(1);Repici, A.(1,6);Armuzzi, A.(1,5);Vetrano, S.(1,2);
Created: Friday, 14 July 2023, 10:48 AM
P092: Serological assessment of wound healing in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

S. Sun1*, M.A. Karsdal1, J.H. Mortensen1, Y. Luo1, J. Kjeldsen2, A. Krag2, M.D. Jensen3, A.-C. Bay-Jensen1, T. Manon-Jensen1

Created: Thursday, 21 February 2019, 9:14 AM
P093 Crosstalk between Toll-like receptor 4 and enteric serotonergic pathways in a mouse model of dinitrobenzene sulfonic acid-induced colitis
Year: 2020
Source:

ECCO'20 Vienna

Authors:

S. Cerantola1, M. Ridolfi1, S. Faggin1, M. Tegon1, G. Bussolaro1, E. Salviato1, M. Bistoletti2, V. Caputi1, C. Giaroni2, M.C. Giron1

Created: Thursday, 30 January 2020, 10:12 AM
P093: 15-d-PGJ2 – a possible regulator of iron homeostasis
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

J. Martin*1, 2, S. Ulrich-Rueckert2, J. Stein1, 3

Created: Friday, 22 February 2019, 9:49 AM
P093: CCL20 and CCR6 on peripheral blood mononuclear cells (PBMC) in inflammatory bowel disease (IBD): a more potent chemokine in ulcerative colitis?
Year: 2018
Source: ECCO '18 Vienna
Authors:

H.K. Skovdahl1,2*, J.K. Damaas1,2,3, A.v.B. Granlund1,2, A.E. Ostvik1,2,4,5, B. Doseth1,5, T. Bruland1,5, T.E. Mollnes2,6,7,8,9, A.K. Sandvik1,2,4,5

Created: Thursday, 21 February 2019, 9:14 AM
P093: CD4 T-cell transcriptome analysis at baseline predicts clinical remission to anti-TNF agents in ulcerative colitis (UC)
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

S. Subramanian*1, L. Rainbow2, M. Gemmell2, R. Hough3, S. Haldenby2, A. Gureviciute1, M. Lofthouse1, K. Martin1, C. Probert1

Created: Friday, 22 February 2019, 9:41 AM
P093: COVID-19 lockdown and mental health burden in Inflammatory Bowel Disease paediatric patients: a case-control study
Year: 2021
Source: ECCO'21 Virtual
Authors: Milo, F.(1);Romeo, E.F.(2);Rea, F.(2);Grimaldi Capitello, T.(1);De Angelis, P.(2);Tabarini, P.(1);
Created: Wednesday, 2 June 2021, 4:12 PM